Top News

USP Establishes Elemental Impurities Implementation Dates

April 01, 2015

USP announces an implementation date of Jan. 1, 2018 for General Chapters Elemental Impurities-Limits and Elemental Contaminants in Dietary Supplements.

Access to New Medicines Requires Transparency and Collaboration, Says WHO Report

March 26, 2015

The WHO report outlines possible policies that may help governments reduce the high prices of new medicines.

Valeant Adds $1 Billion to Salix Offer, Amid Bid Battle

March 16, 2015

Valeant announced that it would increase its original acquisition agreement with Salix to approximately $15.8 billion.

McNeil Hit with $25 million Fine for Adulterated Medications

March 13, 2015

McNeil-PPC pleads guilty in connection with adulterated infants' and children's over-the-counter liquid medications.

23andMe Adds Therapeutics Unit

March 13, 2015

The company will build an R&D team to find promising drug targets with genetic information submitted by customers in its database.

Drug Spending Highest Since 2003, Says Report

March 11, 2015

Drug spending rose last year at the highest rate since 2003, driven by specialty medicines, according to a report from pharmacy benefit manager Express Scripts.

WHO to Launch Ebola Vaccine Efficacy Trial March 7

March 06, 2015

The agency will employ a ring vaccination method similar to the one used to eradicate smallpox.

FDA Approves First Biosimilar

March 06, 2015

In a landmark decision, FDA approved Zarxio, making it the first biosimilar product in the United States.

Baxter Builds Immunology Portfolio by Acquiring Autoimmune Specialist

March 05, 2015

Baxter has bought SuppreMol, a German biopharmaceutical company that focuses on autoimmune treatments, for €200 million ($225 million USD).

AbbVie to Acquire Pharmacyclics for $21 billion

March 05, 2015

AbbVie’s acquisition of Pharmacyclics establishes the combined company as an emerging leader in hematological oncology.